Top-down Monoclonal Antibody (mAb) Analysis Using CID and ETD Fragmentation and the UNIFI Scientific Information System

Applications | 2016 | WatersInstrumentation
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Pharma & Biopharma
Manufacturer
Waters

Summary

Importance of the Topic


Top-down analysis of monoclonal antibodies offers a direct route to verify amino- and carboxy-terminal sequences and locate post-translational modifications without peptide digestion. This orthogonal strategy complements traditional peptide mapping by providing intact mass context and streamlining the characterization of biotherapeutic proteins.

Objectives and Study Overview


This application study evaluates collision induced dissociation (CID) and electron transfer dissociation (ETD) fragmentation of trastuzumab subunits on a SYNAPT G2-Si HDMS mass spectrometer. Data are processed and reported automatically in the UNIFI Scientific Information System to confirm sequence coverage and identify glycoforms and other modifications.

Methodology and Instrumentation


  • Trastuzumab digested with IdeS protease and reduced with DTT to yield LC, Fd, and Fc/2 fragments.
  • Intact mass profiling and top-down MS-MS by targeted CID or ETD on selected charge states.
  • Bayesian BayesSpray algorithm for deconvolution of raw and isotope-resolved spectra.

Used Instrumentation


  • ACQUITY UPLC H-Class Bio System with Protein BEH C4 column, 80 °C, 0.4 mL/min gradient.
  • SYNAPT G2-Si HDMS Mass Spectrometer in ESI+ mode with ion mobility separation capability.
  • MassLynx v4.1 for acquisition and UNIFI v1.8 for data processing and reporting; ProSight PTM 2.0 for complementary annotation.


Main Results and Discussion


Intact mass deconvolution in UNIFI resolved LC, Fd, and Fc/2 glycoforms (G0, G0F, G1F, G2F). ETD fragmentation of the Fc/2 G0F precursor (765.8 m/z, 33+) yielded 42 c-ions and 41 z-ions (≈38% coverage). CID followed by ion mobility separation produced simplified spectra of singly charged b- and y-ions, assigning 19 b- and 31 y-ions (≈24% coverage) and facilitating terminal sequence confirmation. Exported .PUF files enabled cross-validation with ProSight PTM, showing equivalent fragment assignments.

Benefits and Practical Applications


  • Automated intact mass and top-down workflows accelerate sequence verification and PTM localization.
  • BayesSpray deconvolution and IMS separation reduce manual interpretation of complex spectra.
  • Customizable UNIFI report templates enable standardized reporting across biopharmaceutical laboratories.


Future Trends and Opportunities


Integration of advanced fragmentation methods, deeper integration with AI-driven informatics, high-throughput screening of variant libraries, and enhanced PTM mapping algorithms will expand the utility of top-down mAb analysis for drug development and quality control.

Conclusion


The combination of SYNAPT G2-Si HDMS, BayesSpray deconvolution, and UNIFI automated workflows provides a robust platform for efficient top-down characterization of monoclonal antibodies, supporting comprehensive sequence confirmation and modification profiling.

References


  • Waters Corporation. UNIFI Scientific Information System. Brochure. 2015. 720004686EN.
  • Prosight PTM2.0. Proteomics Center of Excellence, Northeastern University.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
BIOPHARMACEUTICAL - Key Applications
BIOPHARMACEUTICAL PLATFORM SOLUTION Key Applications TABLE OF CONTENTS Biopharmaceutical Platform Solution with UNIFI: Key Applications Intact Protein MS Analysis I Peptide Mapping I Released Glycan Analysis I Bioseparations Biotherapeutic proteins – such as monoclonal antibodies (mAbs), biosimilars, and antibody drug…
Key words
unifi, unifibiopharmaceutical, biopharmaceuticaluplc, uplcglycan, glycanacquity, acquityglycoworks, glycoworksplatform, platformglycans, glycanspeptide, peptideanalysis, analysisbiosimilar, biosimilarsolution, solutionintact, intactinnovator, innovatorwaters
Top-down Characterization of Monoclonal Antibody on an Orbitrap Fusion Lumos Tribrid Mass Spectrometer
Poster Note 64778 Top-down Characterization of Monoclonal Antibody on an Orbitrap Fusion Lumos™ Tribrid Mass Spectrometer Seema Sharma, Stephane Houel, Christopher Mullen, Chad Weisbrod, Romain Huguet, John Syka, Dave Horn, Jonathan Josephs, Jae Schwartz, Vlad Zabrouskov Thermo Fisher Scientific, San…
Key words
abundance, abundancefragmentation, fragmentationantibody, antibodyintact, intactetd, etdrelative, relativemab, mabtop, topdown, downheavy, heavydeglycosylated, deglycosylatedmonoclonal, monoclonaluvpd, uvpdpulses, pulsessing
DATA INDEPENDENT TOP-DOWN MASS SPECTROMETRY FACILITATED BY A NEW MSE PROCESSING TOOL
DATA INDEPENDENT TOP-DOWN MASS SPECTROMETRY FACILITATED BY A NEW MSE PROCESSING TOOL Lindsay J. Morrison and Barbara J. Sullivan Waters Corporation, Beverly, USA METHODS OVERVIEW A software for processing of chromatographic top-down MSE data from the Synapt G2-Si is demonstrated…
Key words
top, topdown, downmse, mseproteins, proteinsdemonstrated, demonstratedprocessing, processingsum, sumsliding, slidingcoverage, coveragescores, scoressequence, sequencegaussianexponential, gaussianexponentialgrppr, grpprimtbx, imtbxscanbyscan
In-depth characterization of monoclonal antibodies
In-depth characterization of monoclonal antibodies
2024|Thermo Fisher Scientific|Applications
Technical note | 003318 Biopharma In-depth characterization of monoclonal antibodies Intact mass analysis and middle-down mass spectrometry approaches on an Orbitrap Ascend BioPharma Tribrid mass spectrometer Authors Goal Jingjing Huang, Christopher Mullen, To assess the performance of the Thermo Scientific™…
Key words
trastuzumab, trastuzumabsubunits, subunitsintact, intactuvpd, uvpdactivation, activationtype, typeethcd, ethcdarb, arbmass, massorbitrap, orbitrapascend, ascendparameters, parametersscan, scanfragmentation, fragmentationtrue
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike